CD1D and melanoma: These scores are useful to provide sufficient complexity to the matrix for further unsupervised clustering analysis, of which purpose is not to evaluate markers with higher or lower correlation but ultimately to observe how the cluster identity of CD1D, CD1B, and FCGRT fluctuates in the context of patients expressing high and low B2M, providing further insight on whether antigen-presentation of glycolipids governed by these genes (12, 19, 35) could be impacted by B2M differential expression in melanoma.